Healthcare Archives - Page 7 of 8

The Bispecific and Complex mAbs Driving Process Development Innovation, Roche

July 4, 2019July 4, 2019 MarketsandMarkets Conferences

According to a statement by the VP of Roche technical development bioprocessing, Wolfgang Kuhne said that the older processes used to produce monoclonal antibodies like Herceptin and Avastin are not sufficient to produce complex and advanced pharmaceuticals. A bioprocess international European summit was held in Vienna, Austria during which delegates were told that making candidates like ACE910 – a bispecific antibody granted breakthrough designation for Haemophilia last September – had required a considerable process development effort. In his statement, he clarified by saying “There are no more classical standard approaches…

Improved version in CAR T-cell therapy seems to eliminate its serious side effects

May 30, 2019June 17, 2019 MarketsandMarkets Conferences

A USC study shows an improved version of CAR T-cell therapy seems to eliminate its serious side effects, which will make the treatment safer and potentially available in outpatient settings. Si – Yi Chen of the USC Norris Comprehensive Cancer Center, professor in the Department of Molecular Microbiology and Immunology at the Keck School of Medicine of USC, and senior author of the study said, “This is a major improvement”. He further added “We’ve made a new CAR molecule that’s just as efficient at killing cancer cells, but it works…

Interview with Ester Lovšin Barle – Speaker at 3rd Annual MarketsandMarkets High Potent Medicines Conference

April 2, 2019 MarketsandMarkets Conferences

MarketsandMarkets recently interviewed Ester Lovsin Barle, Corporate Toxicologist, Lonza regarding 3rd Annual MarketsandMarkets High Potent Medicines Conference taking place on 28th – 29th May 2019 in Milan, Italy. When asked about recent advances in the high potent medicines area and current challenges, and this is what she had to say. 1.What are the recent advances in the high potent medicines area and current challenges that need immediate attention? A – It is acknowledged that the hazards, as qualitative aspects are much easier to assess, communicate and perceive by the general…

Speaker Interview with Vanda Plecko for 4th Annual MarketsandMarkets Infection Control, Sterilization and Decontamination in Healthcare Congress

February 13, 2019February 13, 2019 MarketsandMarkets Conferences

London, UK February 11, 2019 – MarketsandMarkets recently interviewed Vanda Plecko, Consultant Microbiologist & Infection Control Doctor, NHS Highland regarding the 4th Annual MarketsandMarkets Infection control, Sterilization & Decontamination in Healthcare Congress, taking place on 28th February – 1st March 2019 in Hotel Novotel London West, UK. Vanda Plecko currently employed as Consultant Microbiologist and Infection Control Doctor in NHS Highland has published over 50 articles cited in international bases and more than 100 abstracts. Her interests are Infection Prevention in hospitals and community, molecular microbiological typing methods and antimicrobial…

Speaker Interview with Karen Tweed for 4th Annual MarketsandMarkets Infection Control, Sterilization and Decontamination in Healthcare Congress

February 13, 2019February 13, 2019 MarketsandMarkets Conferences

London, UK February 11, 2019 – MarketsandMarkets interviewed recently Karen Tweed, Deputy Operations Director (Decontamination), Northern General Hospital regarding the 4th Annual MarketsandMarkets Infection Control, Sterilization & Decontamination in Healthcare Congress, taking place on 28th February – 1st March 2019 in Hotel Novotel London West, UK. Karen Tweed, Deputy Operations Director (Decontamination), started her career at the Huddersfield Royal Infirmary when she ran the pharmacy sterile manufacturing unit. During this time, she was in the first cohort for her first MSc in Pharmaceutical Technology and Quality Assurance with the Leeds…

Exclusive Speaker Interview with Richard Tedder – Speaker at the 2nd Annual MarketsandMarkets Infectious Diseases Diagnostics Conference

February 12, 2019February 12, 2019 MarketsandMarkets Conferences

London, UK. February 11, 2019 – MarketsandMarkets recently caught up with expert speaker Richard Tedder, Public Health England (PHE) – UK, regarding the conference 2nd Annual MarketsandMarkets Infectious Diseases Diagnostics Conference, taking place on 28th February – 1st March 2019 in Hotel Novotel London West, UK. Richard Tedder is a well know Virologist and Microbiologist and is head of the Blood Borne Viruses, National Infection Service, Public Health England – UK. He was also head of the Department of Virology at University College London. Mr. Tedder first published his work…

Everything about Fungal Infection – Types, Symptoms, Diagnosis and Treatment

February 11, 2019February 11, 2019 MarketsandMarkets Conferences

Fungal infection, most common among humans in the world. Probably everybody gets affected by fungal infection at some stage in life. It is common and is mostly caused due to the harmful fungi present in air, water, soil and plants. Fungal infection is not always dangerous but if it is left untreated or shows long-term consequences then it can get scary; but not if the infection is diagnosed and treated on time. In fact, meningitis and bloodstream fungal infections can be deadly. So, make sure, you do not delay in…

Innovation and application of Artificial Intelligence in Healthcare

December 17, 2018January 19, 2019 MarketsandMarkets Conferences

We live in a technology-driven era that is creating tremendous transformation in every business under the sun. Healthcare industry is no exception to it. The technological force and lightning-fast innovation have brought some great changes in the medical sector. The real-world problems are now effortlessly solved by artificial intelligence. Right from research to managing chronic conditions, risk assessment to overcome health challenges, artificial intelligence is undeniably gaining a lot of momentum, in each aspect of healthcare. Innovative applications that have helped the healthcare sector: The innovative artificial intelligence has aided…

Emerging 4 Trends – Cancer Immunotherapy Biomarkers

December 17, 2018 MarketsandMarkets Conferences

Cancer immunotherapy has turned out to be a revolutionary treatment to fight against this largest group of diseases in the world. The artificial stimulation of the immune system enhances the natural ability of the body to fight against cancer. The field on immunotherapy shows a great potential in treating a wide range of types of cancers. Over 8,000 cancer immunotherapy experiments are taking place in clinical trials along with which includes rapid development of biomarkers. The smart and effective immunotherapy is already transforming cancer treatment approach while biomarkers, in addition,…